Ventricular fibrillation induced in animals pretreated with sotalol, a
class III antiarrhythmic agent, would spontaneously terminate and rev
ert into a sinus rhythm. This phenomenon has been atributed to the cla
ss III action of this drug, prolongation of myocardial action potentia
l duration and effective refractory period. Since various observations
suggested that these alone cannot explain the defibrillating phenomen
on, we hypothesised that sotalol affeced ventricular intercellular syn
chronization by increasing intercellular coupling. Our recent experime
ntal studies have shown that sotalol antagonized the cellular decoupli
ng to guinea pig ventricular muscle strip caused by perfusion with eit
her a hypoxic normal Tyrode's solution or an oxygenated high Ca2+ Tyro
de's solution. We assumed that the most likely mechanism for the resto
ration of intercellular coupling would be by increasing intracellular
cAMP concentration. In order to test this hypothesis, we studied the m
odification of this sotalol-induced recoupling by a cAMP dependent pro
tein kinase inhibitor. The results clearly supported our assumption si
nce the addition of Arg-Gly-Tyr-Ala-Leu-Gly (pure A- kinase inhibitor)
prevented the aforementioned cellular recoupling action of sotalol in
a dose-dependent manner. It can thus be concluded that changes in int
racellular cAMP level are involved in the synchronizing/defibrillating
effect of sotalol.